50 research outputs found

    Evaluation of Antimicrobial Susceptibility of Enterobacteriaceae Causing Urinary Tract Infections in Africa

    No full text
    Our objective was to evaluate the antimicrobial susceptibility of Enterobacteriaceae causing urinary tract infections (UTIs) in adults in Africa. The PubMed database was systematically searched to identify relevant studies published after 2000. Google, World Health Organization, and African Field Epidemiology networks were also searched. Twenty-eight studies, accounting for 381,899 urine isolates from 14 African countries, met the inclusion criteria. Escherichia coli, Klebsiella spp., and Proteus spp. were the most commonly encountered uropathogens. Cefotaxime, imipenem, fosfomycin, and ciprofloxacin were the antibiotics with the highest activity against E. coli isolates from outpatients, with susceptibility being 92 to 99, 100, 100, and 68 to 91%, respectively. The susceptibility among Klebsiella spp. isolates from outpatients varied from 80 to 100% for amikacin and from 53 to 100% for ciprofloxacin, while susceptibility was 74 to 78, 97, and 77% for ciprofloxacin, amikacin, and fosfomycin, respectively, among Klebsiella species isolates from inpatients or patients with hospital-acquired UTIs. With regard to Proteus spp., the highest activity was observed among fluoroquinolones; 71 to 100% of the P. mirabilis isolates were susceptible to ciprofloxacin in four studies, and 74 to 100% of the P. vulgaris isolates were susceptible to ofloxacin in two studies. The currently available evidence suggests that the antimicrobial susceptibility patterns of Enterobacteriaceae uropathogens in African countries were similar to those in countries of southeast Europe. Further original studies are warranted from African countries for which there is limited published data

    Morbidity and outcomes of foreign travelers in Zakynthos island, Greece: a retrospective study.

    No full text
    BACKGROUND: Although there is satisfactory recording of diseases affecting travelers visiting developing countries, little is known regarding morbidity of travelers when visiting developed countries. We sought to evaluate the morbidity of foreign travelers in Zakynthos, a popular Greek island attracting large number of foreign tourists every summer. METHODS: Data from foreign travelers that accommodated in Zakynthos and sought medical services from the private offices of Zante Medical Care from May 1 to October 30 2012 were retrospectively analyzed. RESULTS: Two thousand six hundred and eighty-eight patients were included in the study. The mean age (Ā± SD) of the patients whom the age was recorded was 29.6 (Ā± 18.3) and 51.5% of them were from 18 to 40 years old. Disorders of the respiratory tract (32.7%), dermatologic conditions (21.1%), musculoskeletal injuries (16.4%), and gastrointestinal disorders (16.3%) were the four most prevalent clinical categories among patients. Ear disorder was the most common syndromic description (14.5%) among which 81.2% were ear infections; otitis externa and otitis media were diagnosed in 8.5% and 3.3% patients in total. The most common specific diagnosis was gastroenteritis (14.3%). Insect bite and sunburn were the most common diagnosis (6.5% and 3.8%, respectively) among patients with a dermatologic condition. Ear infection was the most common diagnosis in pediatric patients. CONCLUSION: Disorders mainly of the upper respiratory tract were the predominant causes of illness among foreign travelers in Zakynthos. Traveler's diarrhea was the most common specific diagnosis but the prevalence within the total population was not very high

    Impact of vacuum-assisted closure (VAC) therapy on clinical outcomes of patients with sternal wound infections: a meta-analysis of non-randomized studies.

    Get PDF
    OBJECTIVE: To examine the impact of VAC therapy on mortality of patients with sternal wound infections after cardiothoracic surgery. SUMMARY BACKGROUND DATA: Controversial results regarding mortality of patients with sternal wound infections were published. METHODS: We performed a systematic search in PubMed and Scopus. Mortality was the primary outcome of the meta-analysis. Recurrences, complications and length of stay were secondary outcomes. RESULTS: Twenty-two retrospective studies including 2467 patients were eligible for inclusion. Patients treated with VAC had significantly lower mortality compared to those treated without VAC [2233 patients, RRā€Š=ā€Š0.40, (95% CI 0.28, 0.57)]. This finding was consistent regardless of the study design, the exclusion of studies with positive findings, the criteria for establishment of the compared groups, the time of mortality assessment or the type of infections under study, provided that adequate data was available. VAC therapy was associated with fewer recurrences (RRā€Š=ā€Š0.34, 95% CI: 0.19-0.59). The meta-analysis did not show any difference in the length of stay (RRā€Š=ā€Š-2.25, 95% CI: -7.52-3.02). CONCLUSIONS: VAC therapy was associated with lower mortality than other surgical techniques in retrospective cohorts of patients with DSWIs following cardiothoracic surgery

    Continuous versus Conventional Infusion of Amphotericin B Deoxycholate: A Meta-Analysis

    No full text
    <div><p>Background</p><p>Treatment with Amphotericin B (AmB) deoxycholate, which is still used widely, particularly in low-resource countries, has been challenged due to nephrotoxicity. We sought to study whether continuous infusion of AmB deoxycholate reduces nephrotoxicity retaining, however, the effectiveness of the drug.</p><p>Methods</p><p>PubMed and Scopus databases were systematically searched to identify studies comparing the outcomes of patients receiving 24-h infusion of AmB (ā€œcontinuous groupā€) and those receiving 2ā€“6-h infusion of AmB (ā€œconventional groupā€). Nephrotoxicity and all-cause mortality were the primary outcomes of the review, while treatment failure was the secondary outcome.</p><p>Results</p><p>Five studies met the inclusion criteria; one randomized controlled trial, two prospective cohort studies, and two retrospective cohort studies. The majority of patients were neutropenic with an underlying hematologic malignancy. All 5 studies (392 patients) provided data regarding the development of nephrotoxicity. A non-significant trend towards lower nephrotoxicity was observed for patients receiving continuous infusion of AmB compared with those receiving conventional infusion [RRā€Š=ā€Š0.61 (95% CI 0.36, 1.02)]. Four studies (365 patients) provided data regarding mortality; no relevant difference was detected between patients receiving continuous and those receiving conventional infusion of AmB [RRā€Š=ā€Š0.81 (95% CI 0.36, 1.83)]. Data on treatment failure of the two methods of administration was insufficient for meaningful conclusions.</p><p>Conclusion</p><p>The available evidence from mainly non-randomized studies suggests that continuous infusion of AmB deoxycholate might offer an advantage over the conventional infusion regarding the development of nephrotoxicity, without compromising patient survival. Further randomized studies are needed to investigate this issue.</p></div

    Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections

    No full text
    We evaluated the number of deaths attributable to carbapenem-resistant Enterobacteriaceae by using studies from around the world published before April 9, 2012. Attributable death was defined as the difference in all-cause deaths between patients with carbapenem-resistant infections and those with carbapenem-susceptible infections. Online databases were searched, and data were qualitatively synthesized and pooled in a metaanalysis. Nine studies met inclusion criteria: 6 retrospective caseā€“control studies, 2 retrospective cohort studies, and 1 prospective cohort study. Klebsiella pneumoniae was the causative pathogen in 8 studies; bacteremia was the only infection in 5 studies. We calculated that 26%ā€“44% of deaths in 7 studies were attributable to carbapenem resistance, and in 2 studies, which included bacteremia and other infections, āˆ’3% and āˆ’4% of deaths were attributable to carbapenem resistance. Pooled outcomes showed that the number of deaths was significantly higher in patients with carbapenem-resistant infections and that the number of deaths attributable to carbapenem resistance is considerable

    Main characteristics of the included studies.

    No full text
    *<p>In this study, nephrotoxicity was not defined by the investigators. For the purpose of our study, we considered as nephrotoxicity the number of patients who had ā‰„1.5 times baseline creatinine serum concentration. The number of patients with hypokalaemia was not added, because many of them may have been also included in those with elevated serum concentration creatinine.</p><p><b>Abbreviations</b> AmB: amphotericin B, RCT: randomized controlled trial, pts: patients, CTC: common toxicity criteria, WHO: world health organization.</p

    Forest plot depicting the risk ratios (RR) of mortality for patients receiving continuous versus conventional infusion of amphotericin B deoxycholate, stratified by non-randomized and randomized studies.

    No full text
    <p>(Vertical lineā€Š=ā€Šā€œno differenceā€ point between the two regimens. Squaresā€Š=ā€Šrisk ratios; Diamondsā€Š=ā€Špooled risk ratios for all studies. Horizontal linesā€Š=ā€Š95% confidence intervals).</p

    Forest plot depicting the risk ratios (RR) of nephrotoxicity for patients receiving continuous versus conventional infusion of amphotericin B deoxycholate, stratified by non-randomized and randomized studies.

    No full text
    <p>(Vertical lineā€Š=ā€Šā€œno differenceā€ point between the two regimens. Squaresā€Š=ā€Šrisk ratios; Diamondsā€Š=ā€Špooled risk ratios for all studies. Horizontal linesā€Š=ā€Š95% confidence intervals).</p

    Demographic characteristics of 2,688 patients.

    No full text
    <p><sup>*</sup>Age was not recorded for 92 patients, while gender was not recorded for 7 patients.</p><p><sup>**</sup> The remaining travelers were from Italy (36), former Yugoslav Republic of Macedonia (30), Finland (29), Sweden (27), Slovenia (26), Ireland (24), Bulgaria (17), Austria (16), Belgium (10), Germany (10), Norway (10), Croatia (11), Switzerland (5), Slovakia (2), Lithuania (2), Australia (1), France (1), Ukraine (2), Brazil (1), Bosnia (1), while relevant data was not recorded from 5 travelers.</p><p><b>Abbreviations</b></p><p>SD: standard deviation, y: year, F: female, UK: United Kingdom, SRB: Serbia, HU: Hungary, OR: odds ratio, CI: confidence interval</p
    corecore